{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:58Z","timestamp":1791260638606,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1124\/jpet.119.264762","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T23:44:20Z","timestamp":1585007060000},"page":"370-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor"],"prefix":"10.1016","volume":"373","author":[{"given":"Wenqi","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Agbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadley","family":"Cameron-Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff L.","family":"Staudinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.264762_bib1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbrc.2011.02.048","article-title":"Acetylation of pregnane X receptor protein determines selective function independent of ligand activation","volume":"406","author":"Biswas","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.119.264762_bib2","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/me.2003-0327","article-title":"The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha","volume":"18","author":"Blanquart","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.119.264762_bib3","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/mol.104.009019","article-title":"Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor","volume":"67","author":"Burk","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.264762_bib4","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/dmd.106.014456","article-title":"Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways","volume":"35","author":"Cerveny","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/dmd.31.7.908","article-title":"Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile","volume":"31","author":"Chen","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib6","doi-asserted-by":"crossref","first-page":"10361","DOI":"10.1158\/0008-5472.CAN-06-4758","article-title":"Human pregnane X receptor and resistance to chemotherapy in prostate cancer","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.119.264762_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.tips.2012.03.003","article-title":"Pregnane X receptor as a target for treatment of inflammatory bowel disorders","volume":"33","author":"Cheng","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.119.264762_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.110.170225","article-title":"Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation","volume":"335","author":"Cheng","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.264762_bib9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1210\/me.2004-0346","article-title":"Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin","volume":"19","author":"Chrencik","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.119.264762_bib10","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1124\/dmd.115.065201","article-title":"SUMOylation and ubiquitylation circuitry controls pregnane X receptor biology in hepatocytes","volume":"43","author":"Cui","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bbagrm.2016.02.008","article-title":"A SUMO-acetyl switch in PXR biology","volume":"1859","author":"Cui","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.119.264762_bib12","first-page":"809","article-title":"Expression of liver phenotypes in cultured mouse hepatoma cells","volume":"64","author":"Darlington","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.119.264762_bib13","doi-asserted-by":"crossref","first-page":"38225","DOI":"10.1074\/jbc.274.53.38225","article-title":"Serine 157, a retinoic acid receptor alpha residue phosphorylated by protein kinase C in vitro, is involved in RXR.RARalpha heterodimerization and transcriptional activity","volume":"274","author":"Delmotte","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.264762_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/toxsci\/kfj163","article-title":"The mycoestrogen zearalenone induces CYP3A through activation of the pregnane X receptor","volume":"91","author":"Ding","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.119.264762_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/jpet.104.076331","article-title":"Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathway","volume":"312","author":"Ding","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.264762_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1124\/jpet.105.085225","article-title":"The ratio of constitutive androstane receptor to pregnane X receptor determines the activity of guggulsterone against the Cyp2b10 promoter","volume":"314","author":"Ding","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.264762_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bcp.2004.11.025","article-title":"Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C","volume":"69","author":"Ding","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.119.264762_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2091-11-23","article-title":"Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells","volume":"11","author":"Dong","year":"2010","journal-title":"BMC Biochem"},{"key":"10.1124\/jpet.119.264762_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00204-012-0937-9","article-title":"The role of residues T248, Y249 and T422 in the function of human pregnane X receptor","volume":"87","author":"Doricakova","year":"2013","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.119.264762_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bcp.2013.10.015","article-title":"Identification and characterization of phosphorylation sites within the pregnane X receptor protein","volume":"87","author":"Elias","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.119.264762_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.placenta.2011.04.014","article-title":"Characterisation of the nuclear receptors FXR, PXR and CAR in normal and cholestatic placenta","volume":"32","author":"Geenes","year":"2011","journal-title":"Placenta"},{"key":"10.1124\/jpet.119.264762_bib22","doi-asserted-by":"crossref","first-page":"14581","DOI":"10.1074\/jbc.M010173200","article-title":"Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin","volume":"276","author":"Geick","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.264762_bib23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1101\/gad.1773109","article-title":"Cooperative NCoR\/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways","volume":"23","author":"Ghisletti","year":"2009","journal-title":"Genes Dev"},{"key":"10.1124\/jpet.119.264762_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1073\/pnas.0237082100","article-title":"Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor","volume":"100","author":"Goodwin","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.264762_bib25","first-page":"1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.264762_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","article-title":"Cytochrome P-450 3A4: regulation and role in drug metabolism","volume":"39","author":"Guengerich","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.119.264762_bib27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0026-895X(24)12334-6","article-title":"Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor","volume":"61","author":"Guo","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.264762_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","article-title":"Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)","volume":"21","author":"Hodges","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.119.264762_bib29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/jpet.110.171744","article-title":"Pregnane X receptor is SUMOylated to repress the inflammatory response","volume":"335","author":"Hu","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.264762_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/dmdi-2013-0036","article-title":"Pregnane X receptor (PXR)--a contributor to the diabetes epidemic?","volume":"29","author":"Hukkanen","year":"2014","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1124\/jpet.119.264762_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/mol.105.013375","article-title":"Regulation and binding of pregnane X receptor by nuclear receptor corepressor silencing mediator of retinoid and thyroid hormone receptors (SMRT)","volume":"69","author":"Johnson","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.264762_bib32","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.2741\/3893","article-title":"Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver disease","volume":"16","author":"Kakizaki","year":"2011","journal-title":"Front Biosci"},{"key":"10.1124\/jpet.119.264762_bib33","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2174\/138945009789735174","article-title":"Xenobiotic-sensing nuclear receptors CAR and PXR as drug targets in cholestatic liver disease","volume":"10","author":"Kakizaki","year":"2009","journal-title":"Curr Drug Targets"},{"key":"10.1124\/jpet.119.264762_bib34","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.264762_bib35","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s11095-013-1101-9","article-title":"Identification of three novel natural product compounds that activate PXR and CAR and inhibit inflammation","volume":"30","author":"Kittayaruksakul","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.119.264762_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0092-8674(00)80900-9","article-title":"An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway","volume":"92","author":"Kliewer","year":"1998","journal-title":"Cell"},{"key":"10.1124\/jpet.119.264762_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/mol.108.051904","article-title":"Nuclear xenobiotic receptor pregnane X receptor locks corepressor silencing mediator for retinoid and thyroid hormone receptors (SMRT) onto the CYP24A1 promoter to attenuate vitamin D3 activation","volume":"75","author":"Konno","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.264762_bib38","doi-asserted-by":"crossref","first-page":"e0164087","DOI":"10.1371\/journal.pone.0164087","article-title":"Role of PXR in hepatic cancer: its influences on liver detoxification capacity and cancer progression","volume":"11","author":"Kotiya","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/jpet.119.264762_bib39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI3703","article-title":"The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions","volume":"102","author":"Lehmann","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.119.264762_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1124\/mol.108.047845","article-title":"Preferential physical and functional interaction of pregnane X receptor with the SMRTalpha isoform","volume":"75","author":"Li","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.119.264762_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/jpet.109.157180","article-title":"A systematic analysis of predicted phosphorylation sites within the human pregnane X receptor protein","volume":"331","author":"Lichti-Kaiser","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.119.264762_bib42","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1124\/dmd.108.021774","article-title":"The traditional Chinese herbal remedy tian xian activates pregnane X receptor and induces CYP3A gene expression in hepatocytes","volume":"36","author":"Lichti-Kaiser","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib43","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1074\/jbc.M807426200","article-title":"Cyclic AMP-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner","volume":"284","author":"Lichti-Kaiser","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.264762_bib44","doi-asserted-by":"crossref","first-page":"30650","DOI":"10.1074\/jbc.M806132200","article-title":"Cyclin-dependent kinase 2 negatively regulates human pregnane X receptor-mediated CYP3A4 gene expression in HepG2 liver carcinoma cells","volume":"283","author":"Lin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.119.264762_bib45","first-page":"321","article-title":"Nuclear receptor coregulators: cellular and molecular biology","volume":"20","author":"McKenna","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.119.264762_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0304-4165(02)00481-6","article-title":"Functional and structural comparison of PXR and CAR","volume":"1619","author":"Moore","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.119.264762_bib47","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","article-title":"St. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor","volume":"97","author":"Moore","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.264762_bib48","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/mend.16.5.0828","article-title":"Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors","volume":"16","author":"Moore","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.119.264762_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tibs.2004.04.006","article-title":"Mechanism of the nuclear receptor molecular switch","volume":"29","author":"Nagy","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/jpet.119.264762_bib50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/135965350400900510","article-title":"Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA","volume":"9","author":"Owen","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1124\/jpet.119.264762_bib51","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbagrm.2016.01.006","article-title":"Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity","volume":"1859","author":"Pasquel","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.119.264762_bib52","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/156802612799436641","article-title":"General molecular biology and architecture of nuclear receptors","volume":"12","author":"Pawlak","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/jpet.119.264762_bib53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrm1680","article-title":"Controlling nuclear receptors: the circular logic of cofactor cycles","volume":"6","author":"Perissi","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/jpet.119.264762_bib54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molcel.2008.01.020","article-title":"TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR\/SMRT transcriptional repression checkpoints","volume":"29","author":"Perissi","year":"2008","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.119.264762_bib55","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1124\/dmd.108.024695","article-title":"A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor","volume":"37","author":"Pondugula","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1517\/17425250903012360","article-title":"Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression","volume":"5","author":"Pondugula","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.119.264762_bib57","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1021\/jf073350e","article-title":"Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals","volume":"56","author":"Satsu","year":"2008","journal-title":"J Agric Food Chem"},{"key":"10.1124\/jpet.119.264762_bib58","doi-asserted-by":"crossref","first-page":"G1114","DOI":"10.1152\/ajpgi.00528.2006","article-title":"Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression","volume":"292","author":"Shah","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.119.264762_bib59","doi-asserted-by":"crossref","first-page":"13801","DOI":"10.1073\/pnas.212494599","article-title":"Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR)","volume":"99","author":"Sonoda","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.264762_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2019.02.002","article-title":"Clinical applications of small molecule inhibitors of Pregnane X receptor","volume":"485","author":"Staudinger","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.119.264762_bib61","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1517\/17425255.2.6.847","article-title":"Pregnane X receptor and natural products: beyond drug-drug interactions","volume":"2","author":"Staudinger","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.119.264762_bib62","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.264762_bib63","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1124\/dmd.31.5.523","article-title":"Regulation of drug transporter gene expression by nuclear receptors","volume":"31","author":"Staudinger","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2011.02.011","article-title":"Post-translational modification of pregnane x receptor","volume":"64","author":"Staudinger","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.119.264762_bib65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/17425250903483215","article-title":"Nuclear receptor-mediated regulation of carboxylesterase expression and activity","volume":"6","author":"Staudinger","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.119.264762_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.115.066308","article-title":"Threonine-408 regulates the stability of human pregnane X receptor through its phosphorylation and the CHIP\/chaperone-autophagy pathway","volume":"44","author":"Sugatani","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1124\/dmd.109.029785","article-title":"Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression","volume":"38","author":"Sugatani","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib68","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1124\/dmd.112.046748","article-title":"Regulation of pregnane X receptor (PXR) function and UGT1A1 gene expression by posttranslational modification of PXR protein","volume":"40","author":"Sugatani","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/dmd.114.062307","article-title":"Pregnane X receptor modulates the inflammatory response in primary cultures of hepatocytes","volume":"43","author":"Sun","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib70","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/87912","article-title":"The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux","volume":"7","author":"Synold","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/jpet.119.264762_bib71","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1021\/bi0268753","article-title":"2.1 A crystal structure of human PXR in complex with the St. John\u2019s wort compound hyperforin","volume":"42","author":"Watkins","year":"2003","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.119.264762_bib72","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1126\/science.1060762","article-title":"The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity","volume":"292","author":"Watkins","year":"2001","journal-title":"Science"},{"key":"10.1124\/jpet.119.264762_bib73","article-title":"Association between PXR polymorphisms and cancer risk: a systematic review and meta-analysis","volume":"38","author":"Wen","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1124\/jpet.119.264762_bib74","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1124\/dmd.30.9.951","article-title":"Insights from a three-dimensional model into ligand binding to constitutive active receptor","volume":"30","author":"Xiao","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.119.264762_bib75","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1073\/pnas.051014398","article-title":"An essential role for nuclear receptors SXR\/PXR in detoxification of cholestatic bile acids","volume":"98","author":"Xie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.119.264762_bib76","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1124\/dmd.109.026989","article-title":"Regulation of tissue-specific carboxylesterase expression by pregnane x receptor and constitutive androstane receptor","volume":"37","author":"Xu","year":"2009","journal-title":"Drug Metab Dispos"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524259012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.264762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:07:07Z","timestamp":1739970427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524259012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0022356524259012"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.264762","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.264762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}